Expanded Access as a source of real-world data: An overview of FDA and EMA approvals

Research output: Contribution to journal › Article › Academic › peer-review

16 Citations (Scopus)

2 Downloads (Pure)

Original language	English
Pages (from-to)	1819-1826
Number of pages	8
Journal	British Journal of Clinical Pharmacology
Volume	86
Issue number	9
DOIs	https://doi.org/10.1111/bcp.14284
Publication status	Published - 2020

Access to Document

@article{9e1d8816217642e3b4b796b9d632c728,

title = "Expanded Access as a source of real-world data: An overview of FDA and EMA approvals",

author = "Tobias Polak and {van Rosmalen}, Joost and {Uyl - de Groot}, Carin",

year = "2020",

doi = "10.1111/bcp.14284",

language = "English",

volume = "86",

pages = "1819--1826",

journal = "British Journal of Clinical Pharmacology",

issn = "0306-5251",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "9",

}

TY - JOUR

T1 - Expanded Access as a source of real-world data: An overview of FDA and EMA approvals

AU - Polak, Tobias

AU - van Rosmalen, Joost

AU - Uyl - de Groot, Carin

PY - 2020

Y1 - 2020

U2 - 10.1111/bcp.14284

DO - 10.1111/bcp.14284

M3 - Article

VL - 86

SP - 1819

EP - 1826

JO - British Journal of Clinical Pharmacology

JF - British Journal of Clinical Pharmacology

SN - 0306-5251

IS - 9

ER -